Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Basilea announces start of first‑in‑human study of novel antibiotic BAL2420

Summary by WFMZ
Allschwil, Switzerland, March 23, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage

1 Articles

WFMZWFMZ
Center

Basilea announces start of first‑in‑human study of novel antibiotic BAL2420

Allschwil, Switzerland, March 23, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage

·Pennsylvania, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

WFMZ broke the news in Pennsylvania, United States on Monday, March 23, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Allschwil icon

Allschwil

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal